Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$798M |
| 2 |
Netflix
NFLX
|
+$608M |
| 3 |
UnitedHealth
UNH
|
+$517M |
| 4 |
Apple
AAPL
|
+$461M |
| 5 |
GE Vernova
GEV
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$527M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 3 |
Meta Platforms (Facebook)
META
|
+$362M |
| 4 |
Advanced Micro Devices
AMD
|
+$328M |
| 5 |
Palantir
PLTR
|
+$327M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 15.79% |
| 3 | Consumer Discretionary | 12.36% |
| 4 | Financials | 11.53% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
901
iShares 0-5 Year Investment Grade Corporate Bond ETF
SLQD
$2.43B
| $13.4M | 0.02% |
265,500
-108,800
| -29% | -$5.46M |
2023 Q3
7 quarters
|
|
902
Park Aerospace
PKE
$574M
| $13.3M | 0.02% |
902,997
-16,600
| -2% | -$225K |
2013 Q2
48 quarters
|
|
903
Privia Health
PRVA
$2.66B
| $13.3M | 0.02% |
579,100
+268,700
| +87% | +$6.22M |
2024 Q2
4 quarters
|
|
904
Genco Shipping & Trading
GNK
$1.16B
| $13.3M | 0.02% |
1,014,604
-32,900
| -3% | -$435K |
2017 Q1
33 quarters
|
|
905
Amphastar Pharmaceuticals
AMPH
$1.13B
| $13.2M | 0.02% |
576,500
+81,500
| +16% | +$2.02M |
2017 Q4
30 quarters
|
|
906
LeMaitre Vascular
LMAT
$1.85B
| $13.2M | 0.02% |
158,700
+4,400
| +3% | +$368K |
2020 Q4
18 quarters
|
|
907
InterContinental Hotels
IHG
$23.5B
| $13.1M | 0.02% |
113,900
-20,000
| -15% | -$2.24M |
2021 Q1
17 quarters
|
|
|
OLO
908
DELISTED
Olo Inc
OLO
| $13.1M | 0.02% |
1,470,660
-491,540
| -25% | -$3.81M |
2021 Q4
14 quarters
|
|
909
CVR Energy
CVI
$5.83B
| $13.1M | 0.02% |
486,584
-176,600
| -27% | -$3.89M |
2017 Q2
32 quarters
|
|
910
Patrick Industries
PATK
$2.04B
| $13M | 0.02% |
+141,403
| New | +$12M |
2025 Q2
0 quarters
|
|
911
Cable One
CABO
$63.2M
| $13M | 0.02% |
96,000
+57,900
| +152% | +$10.9M |
2015 Q4
38 quarters
|
|
912
Dorman Products
DORM
$3.57B
| $13M | 0.02% |
106,100
+21,900
| +26% | +$2.66M |
2024 Q1
5 quarters
|
|
|
LKFT
913
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.95B
| $13M | 0.02% |
464,700
+133,900
| +40% | +$3.59M |
2019 Q4
22 quarters
|
|
914
Perion Network
PERI
$348M
| $13M | 0.02% |
1,279,048
+207,639
| +19% | +$1.98M |
2013 Q2
48 quarters
|
|
915
O-I Glass
OI
$934M
| $13M | 0.02% |
878,800
+399,800
| +83% | +$5.11M |
2024 Q3
3 quarters
|
|
916
Civeo
CVEO
$332M
| $12.9M | 0.02% |
559,632
-54,716
| -9% | -$1.16M |
2014 Q4
42 quarters
|
|
917
Western Digital
WDC
$149B
| $12.9M | 0.02% |
201,833
+131,900
| +189% | +$6.28M |
2024 Q3
3 quarters
|
|
|
GTLS
918
DELISTED
Chart Industries
GTLS
| $12.9M | 0.02% |
78,400
-28,800
| -27% | -$4.23M |
2025 Q1
1 quarter
|
|
919
Check Point Software Technologies
CHKP
$14B
| $12.9M | 0.02% |
58,208
+42,008
| +259% | +$9.24M |
2017 Q1
33 quarters
|
|
920
MiMedx Group
MDXG
$682M
| $12.9M | 0.02% |
2,107,777
+177,500
| +9% | +$1.18M |
2020 Q4
18 quarters
|
|
921
SPDR Gold Trust
GLD
$142B
| $12.8M | 0.02% |
42,000
+21,300
| +103% | +$6.45M |
2024 Q3
3 quarters
|
|
922
Euronet Worldwide
EEFT
$2.42B
| $12.8M | 0.02% |
126,200
-128,145
| -50% | -$13.2M |
2021 Q3
15 quarters
|
|
923
WSFS Financial
WSFS
$3.85B
| $12.8M | 0.02% |
232,426
+104,200
| +81% | +$5.41M |
2013 Q2
48 quarters
|
|
924
California Water Service
CWT
$2.84B
| $12.8M | 0.02% |
281,000
+75,600
| +37% | +$3.62M |
2024 Q4
2 quarters
|
|
925
Great Southern Bancorp
GSBC
$836M
| $12.8M | 0.02% |
217,200
+6,500
| +3% | +$363K |
2013 Q2
48 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2025 Portfolio in Review
As of Q2 2025, Renaissance Technologies held 4,018 positions worth $75.2B, up 14% from $66.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q2 2025 filing shows 612 new, 1,577 increased, 1,314 reduced and 496 closed positions. Its largest new stake was UnitedHealth: 1,352,129 shares worth $422M. The largest sale was Broadcom, an estimated $527M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2025 buy was UnitedHealth: 1,352,129 shares worth $422M.
- Renaissance Technologies added most to NVIDIA in Q2 2025, an estimated $798M increase.
- Renaissance Technologies's biggest Q2 2025 reduction was Broadcom, cutting an estimated $527M.
- Renaissance Technologies fully exited Advanced Micro Devices in Q2 2025, selling an estimated $328M.
- Renaissance Technologies's ten largest holdings make up 12% of its $75.2B portfolio in Q2 2025.
- Renaissance Technologies opened 612 new positions and closed 496 in Q2 2025.
- Renaissance Technologies's portfolio value rose 14% quarter-over-quarter to $75.2B.
Based on Renaissance Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.